These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6809473)
1. The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects. Andreasen F; Christensen CK; Jacobsen FK; Jansen J; Mogensen CE; Pedersen OL Eur J Clin Invest; 1982 Jun; 12(3):247-55. PubMed ID: 6809473 [TBL] [Abstract][Full Text] [Related]
2. The influence of age on renal and extrarenal effects of frusemide. Andreasen F; Hansen U; Husted SE; Mogensen CE; Pedersen EB Br J Clin Pharmacol; 1984 Jul; 18(1):65-74. PubMed ID: 6743491 [TBL] [Abstract][Full Text] [Related]
3. Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people. Musso CG; Reynaldi J; Vilas M; De Miguel R; Imperiali N; Algranati L Int Urol Nephrol; 2010 Mar; 42(1):273-7. PubMed ID: 19277890 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of frusemide are influenced by age. Andreasen F; Hansen U; Husted SE; Jansen JA Br J Clin Pharmacol; 1983 Oct; 16(4):391-7. PubMed ID: 6626433 [TBL] [Abstract][Full Text] [Related]
5. Furosemide kinetics and dynamics in patients with cirrhosis. Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175 [TBL] [Abstract][Full Text] [Related]
6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum. Lee WI; Yoon WH; Shin WG; Song IS; Lee MG Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h. Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608 [TBL] [Abstract][Full Text] [Related]
9. Acute intravenous administration of potassium chloride to furosemide pretreated dogs. Wong KC; Kawamura R; Hodges MR; Sullivan SP Can Anaesth Soc J; 1977 Mar; 24(2):203-11. PubMed ID: 843974 [TBL] [Abstract][Full Text] [Related]
10. Renal tubular secretion and effects of furosemide. Odlind B; Beermann B Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects. Sechi LA; Marigliano A; Tedde R Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147 [TBL] [Abstract][Full Text] [Related]
13. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit. Pichette V; Geadah D; du Souich P Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313 [TBL] [Abstract][Full Text] [Related]
14. Diuretic effect of butoxymethylen furosemide (FFBU) in healthy subjects: a preliminary study. Licht A; Levy M; Schindel L; Eliakim M Curr Ther Res Clin Exp; 1973 Oct; 15(10):713-26. PubMed ID: 4201316 [No Abstract] [Full Text] [Related]
15. [Furosemide effects in patients with chronic renal insufficiency]. Sperschneider H; Stein G; Traeger A; Keil E Z Gesamte Inn Med; 1984 Jun; 39(11):261-5. PubMed ID: 6475170 [TBL] [Abstract][Full Text] [Related]
16. The influence of intravenous furosemide on the renal excretion pattern of protein and protein degradation products. Andreasen F; Hansen U; Husted SE; Mogensen CE Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):389-93. PubMed ID: 6380214 [TBL] [Abstract][Full Text] [Related]
17. Combination of long-acting furosemide and instant-acting amiloride: pharmacokinetics and pharmacodynamics in human subjects. Flouvat B; Roux A; Leneveu A; Prinseau J; Alexandre JA Fundam Clin Pharmacol; 1991; 5(8):741-52. PubMed ID: 1783363 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic study of the combination of furosemide retard and triamterene. Loew D; Barkow D; Schuster O; Knoell HE Eur J Clin Pharmacol; 1984; 26(2):191-5. PubMed ID: 6723757 [TBL] [Abstract][Full Text] [Related]
19. The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit. Pichette V; Geadah D; du Souich P Br J Pharmacol; 1996 Nov; 119(5):885-90. PubMed ID: 8922736 [TBL] [Abstract][Full Text] [Related]